The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury

Traumatic brain injury (TBI), which is a global public health concern, can take various forms, from mild concussions to blast injuries, and each damage type has a particular mechanism of progression. However, TBI is a condition with complex pathophysiology and heterogenous clinical presentation, whi...

詳細記述

書誌詳細

出版年:	Pharmaceuticals
主要な著者:	Anja Harej Hrkać, Kristina Pilipović, Andrej Belančić, Lea Juretić, Dinko Vitezić, Jasenka Mršić-Pelčić
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2024-10-01
主題:	brain injuries traumatic glucagon-like peptide 1 incretins neuroprotection
オンライン･アクセス:	https://www.mdpi.com/1424-8247/17/10/1313